{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:41:43Z","timestamp":1790804503490,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008793","name":"Universidad del Rosario","doi-asserted-by":"crossref","award":["ABN-011"],"award-info":[{"award-number":["ABN-011"]}],"id":[{"id":"10.13039\/501100008793","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.autrev.2016.07.025","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T15:35:24Z","timestamp":1470411324000},"page":"1094-1108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Pulmonary involvement in systemic sclerosis"],"prefix":"10.1016","volume":"15","author":[{"given":"Adriana","family":"Morales-C\u00e1rdenas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"P\u00e9rez-Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Paula","family":"Mahecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Rojas-Villarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Carrillo-Bayona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Manuel","family":"Anaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2016.07.025_bb0005","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0755-4982(06)74924-7","article-title":"Systemic sclerosis: pathophysiology of a multifaceted disease","volume":"35","author":"Servettaz","year":"2006","journal-title":"Presse Med"},{"key":"10.1016\/j.autrev.2016.07.025_bb0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1568-9972(03)00004-1","article-title":"New insights into the pathogenesis of systemic sclerosis","volume":"2","author":"Tamby","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.07.025_bb0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.berh.2004.03.001","article-title":"Scleroderma\u2014clinical and pathological advances","volume":"18","author":"Denton","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0020","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0025","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10620-007-0018-8","article-title":"Gastrointestinal manifestations of systemic sclerosis","volume":"53","author":"Domsic","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2016.07.025_bb0030","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","article-title":"Systemic sclerosis: demographic, clinical, and serologic features and survival in 1012 Italian patients","volume":"81","author":"Ferri","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2016.07.025_bb0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.autrev.2016.07.025_bb0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ccm.2010.05.004","article-title":"Pulmonary manifestations of scleroderma and mixed connective tissue disease","volume":"31","author":"Hant","year":"2010","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.autrev.2016.07.025_bb0050","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0002-9343(69)90044-8","article-title":"Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls","volume":"46","author":"D'Angelo","year":"1969","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2016.07.025_bb0060","first-page":"755","article-title":"Pulmonary scleroderma","volume":"176","author":"Weaver","year":"1968","journal-title":"Dis Chest"},{"key":"10.1016\/j.autrev.2016.07.025_bb0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1183\/09059180.00005512","article-title":"Scleroderma lung disease","volume":"22","author":"Solomon","year":"2013","journal-title":"Eur Respir Updat"},{"key":"10.1016\/j.autrev.2016.07.025_bb0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10067-006-0302-6","article-title":"The natural course of progressive systemic sclerosis patients with interstitial lung involvement","volume":"26","author":"Benan","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0075","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/radiology.176.3.2389033","article-title":"Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography","volume":"176","author":"Schurawitzki","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.autrev.2016.07.025_bb0080","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.22532","article-title":"Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors","volume":"57","author":"McNearney","year":"2007","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2016.07.025_bb0085","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.114.3.801","article-title":"African\u2013American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease","volume":"114","author":"Greidinger","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2016.07.025_bb0090","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acr.21583","article-title":"Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis","volume":"64","author":"Steele","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2016.07.025_bb0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-94-007-4549-0_19","article-title":"Antiendothelial cells antibodies in patients with systemic sclerosis in relation to pulmonary hypertension and lung fibrosis","volume":"756","author":"Lewandowska","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0100","first-page":"244","article-title":"Risk factors associated with pulmonary arterial hypertension in Colombian patients with systemic sclerosis: review of the literature","volume":"35","author":"Coral-Alvarado","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semarthrit.2007.10.010","article-title":"The immunobiology of systemic sclerosis","volume":"38","author":"Gu","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.autrev.2010.09.012","article-title":"Interstitial lung disease in systemic sclerosis","volume":"10","author":"Bussone","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.07.025_bb0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clim.2011.09.010","article-title":"Is IL-4 a potential therapeutic target in systemic sclerosis-associated pulmonary fibrosis?","volume":"141","author":"Sfikakis","year":"2011","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11926-009-0071-8","article-title":"Pathogenesis of pulmonary fibrosis in systemic sclerosis: lessons from interstitial lung disease","volume":"12","author":"Veraldi","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2016.07.025_bb0125","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.22713","article-title":"Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis","volume":"56","author":"Bogatkevich","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0130","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3899\/jrheum.080633","article-title":"Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma","volume":"36","author":"Hant","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11926-010-0143-9","article-title":"Biomarkers of scleroderma lung disease: recent progress","volume":"13","author":"Hant","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2016.07.025_bb0140","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1164\/ajrccm.152.6.8520747","article-title":"Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids","volume":"152","author":"Honda","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2016.07.025_bb0145","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5","article-title":"Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis","volume":"44","author":"Asano","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0150","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/ajrccm\/148.3.637","article-title":"KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease","volume":"148","author":"Kohno","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.autrev.2016.07.025_bb0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1471-4906(00)01812-3","article-title":"RANTES: a versatile and controversial chemokine","volume":"22","author":"Appay","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0160","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3899\/jrheum.081310","article-title":"Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis","volume":"36","author":"Yanaba","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0165","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0170","first-page":"32","article-title":"Diagnostic value of exhaled nitric oxide to detect interstitial lung disease in systemic sclerosis","volume":"26","author":"Tiev","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2016.07.025_bb0175","series-title":"Association of Psoriasin (S100A7) with clinical manifestations of systemic sclerosis: is its presence in whole saliva a potential predictor of pulmonary involvement?","first-page":"1820","volume":"35","author":"Baldini","year":"2008"},{"key":"10.1016\/j.autrev.2016.07.025_bb0180","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/rheumatology\/kes068","article-title":"Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis","volume":"51","author":"Barnes","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.07.025_bb0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/acr.21799","article-title":"Soluble CD90 as a potential marker of pulmonary involvement in systemic sclerosis","volume":"65","author":"Kollert","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2016.07.025_bb0190","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2230.2007.02678.x","article-title":"Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody","volume":"33","author":"Komura","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0195","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.hlc.2014.02.002","article-title":"Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience","volume":"23","author":"Demir","year":"2014","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.autrev.2016.07.025_bb0200","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1378\/chest.11-0801","article-title":"Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the Scleroderma Lung Study","volume":"142","author":"Theodore","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2016.07.025_bb0205","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1078\/0344-0338-00265","article-title":"Accuracy of high resolution CT in assessing idiopathic pulmonary fibrosis histology by objective morphometric index","volume":"198","author":"Schettino","year":"2002","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.autrev.2016.07.025_bb0210","first-page":"1789","article-title":"High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis","volume":"33","author":"Launay","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0215","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000335473","article-title":"Detection of interstitial lung disease in systemic sclerosis through partitioning of lung transfer for carbon monoxide","volume":"84","author":"Pernot","year":"2012","journal-title":"Respiration"},{"key":"10.1016\/j.autrev.2016.07.025_bb0220","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00296-008-0824-0","article-title":"Patterns of pulmonary function in smoking and nonsmoking patients with progressive systemic sclerosis","volume":"29","author":"Quadrelli","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2016.07.025_bb0225","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2016.07.025_bb0230","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","article-title":"Severe restrictive lung disease in systemic sclerosis","volume":"37","author":"Steen","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0235","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/art.30467","article-title":"Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group","volume":"63","author":"Khanna","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0240","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3899\/jrheum.080447","article-title":"Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma","volume":"36","author":"Garin","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0245","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/RHU.0b013e318261176f","article-title":"High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis","volume":"18","author":"Patiwetwitoon","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0250","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","article-title":"Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome","volume":"165","author":"Bouros","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2016.07.025_bb0255","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society Statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2016.07.025_bb0260","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1164\/ajrccm.158.4.9802119","article-title":"Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients","volume":"158","author":"Cottin","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2016.07.025_bb0265","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2214\/ajr.171.6.9843306","article-title":"Nonspecific interstitial pneumonia with fibrosis: high-resolution CT and pathologic findings","volume":"171","author":"Kim","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0270","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3904\/kjim.1996.11.2.122","article-title":"Nonspecific interstitial pneumonia\/fibrosis: clinical manifestations, histologic and radiologic features","volume":"11","author":"Park","year":"1996","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.autrev.2016.07.025_bb0275","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11547-009-0367-9","article-title":"HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities","volume":"114","author":"Bellia","year":"2009","journal-title":"Radiol Med"},{"key":"10.1016\/j.autrev.2016.07.025_bb0280","series-title":"Systemic sclerosis and idiophatic interstitial pneumonia: histomorphometric differences in lung biopsies","first-page":"529","volume":"35","author":"Parra","year":"2009"},{"key":"10.1016\/j.autrev.2016.07.025_bb0285","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2559.2008.03072.x","article-title":"Arterial and interstitial remodelling processes in non-specific interstitial pneumonia: systemic sclerosis versus idiopathic","volume":"53","author":"De Carvalho","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.autrev.2016.07.025_bb0290","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.rhu.0000083860.27509.f1","article-title":"Bronchiolitis obliterans with organizing pneumonia associated with scleroderma and scleroderma spectrum diseases","volume":"9","author":"Taylor","year":"2003","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0295","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00296-002-0230-y","article-title":"Recurrent bronchiolitis obliterans organizing pneumonia in a patient with limited cutaneous systemic sclerosis","volume":"22","author":"Shimizu","year":"2002","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2016.07.025_bb0300","first-page":"1136","article-title":"Bronchiolitis obliterans organizing pneumonia and scleroderma","volume":"19","author":"Bridges","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0305","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0025-6196(11)63569-6","article-title":"Organizing diffuse alveolar damage associated with progressive systemic sclerosis","volume":"72","author":"Muir","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.autrev.2016.07.025_bb0310","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1148\/radiographics.19.6.g99no211507","article-title":"Clinical and radiologic features of pulmonary edema","volume":"19","author":"Gluecker","year":"1999","journal-title":"Radiographics"},{"key":"10.1016\/j.autrev.2016.07.025_bb0315","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/art.30077","article-title":"Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease","volume":"63","author":"Cottin","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0320","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1148\/radiol.2322031223","article-title":"CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia","volume":"232","author":"Desai","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.autrev.2016.07.025_bb0325","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1161\/CIRCULATIONAHA.106.678334","article-title":"Cardiovascular manifestations of rheumatologic diseases","volume":"116","author":"Roman","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2016.07.025_bb0330","first-page":"643","article-title":"Cardiovascular involvement in patients with systemic sclerosis: insights from electromechanical characteristics of the heart","volume":"11","author":"Karabay","year":"2011","journal-title":"Anadolu Kardiyol Derg"},{"key":"10.1016\/j.autrev.2016.07.025_bb0335","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1378\/chest.12-2768","article-title":"Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort study","volume":"144","author":"Bauer","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2016.07.025_bb0340","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1378\/chest.110.6.1515","article-title":"Prevalence of pulmonary hypertension in limited and diffuse scleroderma","volume":"110","author":"Battle","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2016.07.025_bb0345","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.025_bb0350","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s11547-013-0934-1","article-title":"Pulmonary hypertension and systemic sclerosis: the role of high-resolution computed tomography","volume":"118","author":"Zompatori","year":"2013","journal-title":"Radiol Med"},{"key":"10.1016\/j.autrev.2016.07.025_bb0355","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/RCT.0b013e3182aa7fc5","article-title":"Relationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosis","volume":"38","author":"McCall","year":"2014","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.autrev.2016.07.025_bb0360","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/art.34501","article-title":"Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension","volume":"64","author":"G\u00fcnther","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0365","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000314587","article-title":"Pulmonary capillary hemangiomatosis associated with CREST syndrome: a case report and review of the literature","volume":"80","author":"McGuire","year":"2010","journal-title":"Respiration"},{"key":"10.1016\/j.autrev.2016.07.025_bb0370","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2332\/allergolint.11-RAI-0362","article-title":"2009 ESC\/ERS pulmonary hypertension guidelines and connective tissue disease","volume":"60","author":"Nakanishi","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.autrev.2016.07.025_bb0375","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1529-0131(200003)43:3<699::AID-ANR28>3.0.CO;2-O","article-title":"Pulmonary edema complicating prostacyclin therapy in pulmonary hypertension associated with scleroderma: a case of pulmonary capillary hemangiomatosis","volume":"43","author":"Gugnani","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0380","first-page":"2347","article-title":"Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension","volume":"33","author":"Johnson","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0385","first-page":"1013","article-title":"Systemic sclerosis complicated by diffuse alveolar hemorrhage","volume":"7","author":"Chaer","year":"2001","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.autrev.2016.07.025_bb0390","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/RTI.0000000000000092","article-title":"Aspiration-related lung diseases","volume":"29","author":"Prather","year":"2014","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.autrev.2016.07.025_bb0395","first-page":"215","article-title":"Image interpretation session: 1995","volume":"16","author":"Lichtenstein","year":"1996","journal-title":"Radiographics"},{"key":"10.1016\/j.autrev.2016.07.025_bb0400","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/01.MP.0000037309.04985.B4","article-title":"Idiopathic bronchiolocentric interstitial pneumonia","volume":"15","author":"Yousem","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0405","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1078\/0344-0338-00305","article-title":"Centrilobular fibrosis: a novel histological pattern of idiopathic interstitial pneumonia","volume":"198","author":"de Carvalho","year":"2002","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.autrev.2016.07.025_bb0410","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/thx.2004.031005","article-title":"Challenges in pulmonary fibrosis. 2: bronchiolocentric fibrosis","volume":"62","author":"Cordier","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.autrev.2016.07.025_bb0415","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000156958","article-title":"Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis","volume":"77","author":"De Souza","year":"2009","journal-title":"Respiration"},{"key":"10.1016\/j.autrev.2016.07.025_bb0420","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1378\/chest.121.4.1278","article-title":"Association of malignancy with diseases causing interstitial pulmonary changes","volume":"121","author":"Bouros","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2016.07.025_bb0425","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.autrev.2012.06.003","article-title":"Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature","volume":"12","author":"Colaci","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.07.025_bb0430","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/ard.62.2.146","article-title":"Predictors of end stage lung disease in a cohort of patients with scleroderma","volume":"62","author":"Morgan","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.025_bb0435","first-page":"150","article-title":"Long-term follow-up of patients with scleroderma interstitial lung disease treated with intravenous cyclophosphamide pulse therapy: a single-center experience","volume":"17","author":"Balbir-Gurman","year":"2015","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2016.07.025_bb0440","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.autrev.2015.02.002","article-title":"Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?","volume":"14","author":"Iudici","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.07.025_bb0445","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.semarthrit.2014.09.003","article-title":"Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders","volume":"44","author":"Iudici","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0450","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2016.07.025_bb0455","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00296-014-3026-y","article-title":"Systemic sclerosis: comparison of efficacy of oral cyclophosphamide and azathioprine on skin score and pulmonary involvement-a retrospective study","volume":"34","author":"Poormoghim","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2016.07.025_bb0460","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/1756-185X.12399","article-title":"Two-year experience with mycophenolate mofetil in patients with scleroderma lung disease: a case series","volume":"17","author":"Yilmaz","year":"2014","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.025_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124205","article-title":"Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic review","volume":"10","author":"Omair","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.07.025_bb0470","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3109\/03009742.2013.869617","article-title":"Rituximab for systemic sclerosis: arrest of pulmonary disease progression in five cases. Results of a lower dosage and shorter interval regimen","volume":"43","author":"Moazedi-Fuerst","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0475","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/annrheumdis-2013-204522","article-title":"Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group","volume":"74","author":"Jordan","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.07.025_bb0480","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/1346-8138.12461","article-title":"Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus","volume":"41","author":"Sumida","year":"2014","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2016.07.025_bb0485","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.semarthrit.2014.09.002","article-title":"Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis","volume":"44","author":"Bosello","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0490","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.autrev.2015.07.008","article-title":"Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature","volume":"14","author":"Giuggioli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.07.025_bb0495","doi-asserted-by":"crossref","first-page":"R144","DOI":"10.1186\/ar4606","article-title":"Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study","volume":"16","author":"Fraticelli","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.07.025_bb0500","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/art.39021","article-title":"Survival of adults with systemic sclerosis following lung transplantation: a nationwide cohort study","volume":"67","author":"Bernstein","year":"2015","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.07.025_bb0505","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.transproceed.2014.10.038","article-title":"A case report of living-donor lobar lung transplantation for scleroderma-associated usual interstitial pneumonia: eight years and counting","volume":"47","author":"Laratta","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.autrev.2016.07.025_bb0510","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/j.lpm.2014.01.020","article-title":"Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary working group","volume":"43","author":"Launay","year":"2014","journal-title":"Presse Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216301707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T13:50:11Z","timestamp":1549806611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216301707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":102,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1568997216301707"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.07.025","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary involvement in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}